Global Nuclear Medicine Cyclotron Systems Market Growth 2024-2030

Global Nuclear Medicine Cyclotron Systems Market Growth 2024-2030

Product Code:1090582

Published Date: Apr 02,2024

Pages: 94

Region: Global

Category: Medical Devices & Consumables

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

PDF DOWNLOAD

GET FREE SAMPLE

CUSTOMIZE REQUEST

SELECT A FORMAT

ADD TO BASKET

BUY NOW

Provide comprehensive and accurate analysis and reports according to your exact requirements

Provide comprehensive and accurate analysis and reports according to your exact requirements

CONTACT US

Nuclear Medicine Cyclotron Systems are specialized devices used in the field of nuclear medicine for the production of short-lived radioisotopes. These systems consist of a cyclotron, which is a type of particle accelerator, and associated equipment for radioisotope production. Cyclotrons accelerate charged particles, typically protons, to high speeds and direct them at target materials, resulting in the creation of radioisotopes used in various medical imaging and therapeutic applications. The produced radioisotopes play a crucial role in positron emission tomography (PET) scans and other diagnostic and treatment procedures in nuclear medicine, aiding in the visualization and characterization of physiological processes within the human body.

The global Nuclear Medicine Cyclotron Systems market size is projected to grow from US$ 227 million in 2024 to US$ 297 million in 2030; it is expected to grow at a CAGR of 4.5% from 2024 to 2030.

LP Information, Inc. (LPI) ' newest research report, the “Nuclear Medicine Cyclotron Systems Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Cyclotron Systems sales in 2023, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Cyclotron Systems sales for 2024 through 2030. With Nuclear Medicine Cyclotron Systems sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Cyclotron Systems industry.

This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Cyclotron Systems landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Cyclotron Systems portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Medicine Cyclotron Systems market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Cyclotron Systems and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Cyclotron Systems.

Global core manufacturers of Nuclear Medicine Cyclotron Systems include GE Healthcare, Best Cyclotron Systems and Advanced Cyclotron Systems (ACSI). The top three companies have a market share of about 65%. Asia Pacific is the largest global market for Nuclear Medicine Cyclotron Systems with a market share of approximately 34%, followed by North America and Europe with a market share of 29% and 22%, respectively. In terms of product type, Cyclotron 13-18 MeV is the largest segment with approximately 42% market share. In terms of application, Hospital is the largest downstream segment, accounting for about 60% of the market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Cyclotron Systems market by product type, application, key manufacturers and key regions and countries.

Segmentation by Type:
    Cyclotron Less than 12 MeV
    Cyclotron 13-18 MeV
    Cyclotron 19-24 MeV
    Cyclotron More than 24 MeV

Segmentation by Application:
    Pharmaceutical Industry
    Hospital
    Research & Academics

This report also splits the market by region:
    Americas
        United States
        Canada
        Mexico
        Brazil
    APAC
        China
        Japan
        Korea
        Southeast Asia
        India
        Australia
    Europe
        Germany
        France
        UK
        Italy
        Russia
    Middle East & Africa
        Egypt
        South Africa
        Israel
        Turkey
        GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
    GE Healthcare
    IBA
    Best Cyclotron Systems
    Advanced Cyclotron Systems (ACSI)
    Sumitomo Heavy Industries
    Longevous Beamtech

Key Questions Addressed in this Report
What is the 10-year outlook for the global Nuclear Medicine Cyclotron Systems market?
What factors are driving Nuclear Medicine Cyclotron Systems market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Medicine Cyclotron Systems market opportunities vary by end market size?
How does Nuclear Medicine Cyclotron Systems break out by Type, by Application?